Long-term data with idebenone on respiratory function outcomes in patients with Duchenne muscular dystrophy
Decline in respiratory function in patients with DMD starts during early teenage years and leads to early morbidity and mortality. Published evidence of efficacy for idebenone on respiratory function outcomes is currently limited to 12 months of follow-up time. Here we report data collected as retro...
Những tác giả chính: | Servais, L, Straathof, CSM, Schara, U, Klein, A, Leinonen, M, Hasham, S, Meier, T, De Waele, L, Gordish-Dressman, H, McDonald, CM, Mayer, OH, Voit, T, Mercuri, E, Buyse, GM |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Elsevier
2019
|
Những quyển sách tương tự
-
Lessons Learned from Discontinued Clinical Developments in Duchenne Muscular Dystrophy
Bằng: Theodora Markati, et al.
Được phát hành: (2021-11-01) -
Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy
Bằng: Marshall W. Hogarth, et al.
Được phát hành: (2017-01-01) -
Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy
Bằng: Fatima Amor, et al.
Được phát hành: (2021-06-01) -
Duchenne Muscular Dystrophy
Bằng: J Gordon Millichap
Được phát hành: (1989-05-01) -
Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
Bằng: Frank, DE, et al.
Được phát hành: (2020)